Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio
Radnostix closed the acquisition of key assets from Lucerno Dynamics, including the LARA System technology platform and ELLEXA Explorer software. The acquired IP enhances Radnostix's radiopharma medical device portfolio, offering real-time visualization and improved dosimetry for theranostics administration.
Key figures
- Procedures conducted
- nearly 50,000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.